-
Awarded05/07/2024
-
Today29/04/2025
Utilities
- indicates text translated automatically in your browsing language
MEDICINES SCLEROSIS MULTIPLA VOL I Text automatically translated in your browsing language Automatically translated
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
purchase of the medicinal product - DCI- siponimod in order to ensure the treatment of patients diagnosed with multiple sclerosis and taking into account that the product was introduced into the PNS, the subprogramme for the treatment of multiple sclerosis; in accordance with the requirements of the attached product specification; Deadline for requesting clarifications: on the 18th day before the deadline for submission of tenders and the deadline for replying to requests for clarifications from economic operators: on the 11th day before the deadline for submission of tenders During the framework agreement, the prices shall be adjusted according to the settlement prices in the Technical Rules in force for the National Health Programmes, according to the formula below: new P=old P(awarded following the auction)xP new from the rules/old P from the rules (time of opening the tenders), where: P = price. It is accepted to update the price according to the changes made by administrative acts issued by MS (price orders). The contracting authority reserves the right not to conclude follow-up contracts for one or more products if they will not be necessary or the financial resources will not allow it. Text automatically translated in your browsing language Automatically translated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.